PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F0JL6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $653,261
Award facts
- Contract value 100% obligated
- $653,261.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $653,261.01 to AmerisourceBergen Drug Corp on July 29, 2025, for pharmaceutical and medical supply distribution. The contract, which is a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026, which serves as the primary vehicle for global pharmaceutical support across military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medical products to federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's federal procurement portfolio encompasses brand-name and generic medications, vaccines, specialty therapeutics, and medical devices across multiple therapeutic domains. As a competitively awarded contractor without set-aside designation, AmerisourceBergen demonstrates capability to meet federal medical supply requirements through open competition. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, which will continue to leverage AmerisourceBergen's distribution capabilities as part of a broader federal medical procurement strategy.
Quick answers
Who was awarded contract SPE2D825F0JL6?
SPE2D825F0JL6 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 29, 2025.
How much is contract SPE2D825F0JL6 worth?
The government has obligated $653,261 on SPE2D825F0JL6.
Is contract SPE2D825F0JL6 an order under another contract?
Yes. SPE2D825F0JL6 is a delivery order under SPE2DX22D0030, an indefinite delivery contract.
Was contract SPE2D825F0JL6 competed?
The extent of competition for SPE2D825F0JL6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award